EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics

Michael Desgagné iD, Magali Chartier, Camille Lagard, Sára Ferková iD, Mathieu Choquette, Jean-Michel Longpré iD, Jérôme Côté iD, Pierre-Luc Boudreault iD, Philippe Sarret iD

Angewandte Chemie International Edition · 2024

DOI: 10.1002/anie.202405941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Michael Desgagné und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke…. Hauptthemen laut MEDLINE: Receptors, Neurotensin, Macrocyclic Compounds. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The opioid crisis has highlighted the urgent need to develop non‐opioid alternatives for managing pain, with an effective, safe, and non‐addictive pharmacotherapeutic profile. Using an extensive structure–activity relationship approach, here we have identified a new series of highly selective neurotensin receptor type 2 (NTS2) macrocyclic compounds that exert potent, opioid‐independent analgesia in various experimental pain models. To our knowledge, the constrained macrocycle in which the Ile 12 residue of NT(7–12) was substituted by cyclopentylalanine, Pro 7 and Pro 10 were replaced by allyl‐glycine followed by side‐chain to side‐chain cyclization is the most selective analog targeting NTS2 identified to date ( K i 2.9 nM), showing 30,000‐fold selectivity over NTS1. Of particular importance, this macrocyclic analog is also able to potentiate the analgesic effects of morphine in a dose‐ and time‐dependent manner. Exerting complementary analgesic actions via distinct mechanisms of nociceptive transmission, NTS2‐selective macrocycles can therefore be exploited as opioid‐free analgesics or as opioid‐sparing therapeutics, offering superior pain relief with reduced adverse effects to pain patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, NeurotensinMacrocyclic CompoundsHumansAnimalsStructure-Activity RelationshipAnalgesics, OpioidMiceAnalgesicsMolecular StructurePain

Stichwörter der Autor:innen

GPCRNTS2analgesiacyclic peptidesopioid-sparingpainstructure–activity relationship

Substanzen

Receptors, NeurotensinMacrocyclic CompoundsAnalgesics, OpioidAnalgesicsNTSR2 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, J1H 5N4, Sherbrooke, Québec, Canada.

ORCID-Profile: Michael Desgagné, Sára Ferková, Jean-Michel Longpré, Jérôme Côté, Pierre-Luc Boudreault, Philippe Sarret

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Desgagné, M., Chartier, M., Lagard, C., Ferková, S., Choquette, M., Longpré, J. M., Côté, J., Boudreault, P. L., & Sarret, P. (2024). Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202405941

Vancouver

Desgagné M, Chartier M, Lagard C, Ferková S, Choquette M, Longpré JM, et al. Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202405941

BibTeX
@article{Desgagn2024,
  author = {Desgagné, Michael and Chartier, Magali and Lagard, Camille and Ferková, Sára and Choquette, Mathieu and Longpré, Jean-Michel and Côté, Jérôme and Boudreault, Pierre-Luc and Sarret, Philippe},
  title = {Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  doi = {10.1002/anie.202405941}
}
Kostenlos starten →